{
    "nctId": "NCT00515762",
    "briefTitle": "Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling",
    "officialTitle": "Pilot Trial of Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling (ELASTO-GEL CAPS)in Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Alopecia, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "percentage of patients without persistent alopecia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* age 18-75\n* breast cancer stages II-III\n* adjuvant or neoadjuvant chemotherapy with docetaxel regimens (TAC or anthracyclines followed by docetaxel 100 mg/m2 x 4)\n\nExclusion Criteria:\n\n* contraindications for adjuvant docetaxel and or anthracyclines",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}